Citius Oncology(CTOR)
$0.55+0.01 (+2.24%)
CTOR
Citius Oncology financials statements
$0.55
At close:+0.01 (+2.24%)
Want to see CTOR full AI Analyst Report?
Citius Oncology (CTOR) Financial Statements
132 Followers
Citius Oncology Financial Overview
Citius Oncology's market cap is currently $50.92M. The company's EPS TTM is $-0.48; its P/E ratio is -1.20; Citius Oncology is estimated to report earnings on December 17, 2026, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -23.52M | $ -20.57M | $ -12.12M | $ -9.71M |
| EBITDA | $ -23.49M | $ -20.57M | $ -12.12M | $ 0.00 |
| Net Income | $ -24.76M | $ -21.15M | $ -12.70M | $ -10.87M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 3.92M | $ 112.00 | $ 0.00 | $ 0.00 |
| Total Assets | $ 100.94M | $ 84.37M | $ 47.73M | $ 42.69M |
| Total Debt | $ 3.80M | $ 3.80M | $ 0.00 | $ 0.00 |
| Net Debt | $ -124.80K | $ 3.80M | $ 0.00 | $ 0.00 |
| Total Liabilities | $ 56.08M | $ 38.23M | $ 22.20M | $ 6.42M |
| Stockholders' Equity | $ 44.87M | $ 46.14M | $ 25.54M | $ 36.27M |
| Cash Flow | ||||
| Free Cash Flow | $ -5.49M | $ 126.35K | $ -601.30K | $ -47.97K |
| Operating Cash Flow | $ -5.49M | $ 126.35K | $ -601.30K | $ -47.97K |
| Investing Cash Flow | $ -5.75M | $ -5.00M | $ -1.32M | $ -67.32M |
| Financing Cash Flow | $ 15.17M | $ 4.87M | $ 1.66M | $ 67.66M |
Currency in USD

